ZDA
CELG

Zweig-DiMenna Associates’s Celgene Corp CELG Stock Holding History

Zweig-DiMenna Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-270,040
Closed -$26.8M – 130
2019
Q3 		$26.8M Sell
270,040
-177
-0.1% -$16.8K 2.38% 8
2019
Q2 		$25M Sell
270,217
-8,783
-3% -$834K 2.37% 8
2019
Q1 		$26.3M Buy
+279,000
New +$24.4M 2.93% 4
2016
Q1 		– Sell
-213,325
Closed -$25.5M – 318
2015
Q4 		$25.5M Sell
213,325
-180,957
-46% -$20.9M 1.28% 22
2015
Q3 		$42.6M Buy
+394,282
New +$48.9M 1.85% 8
2015
Q1 		– Sell
-90,351
Closed -$10.1M – 357
2014
Q4 		$10.1M Buy
90,351
+70,848
+363% +$7.47M 0.43% 86
2014
Q3 		$1.85M Buy
19,503
+16,303
+509% +$1.47M 0.08% 135
2014
Q2 		$275K Sell
3,200
-119,800
-97% -$9.11M 0.01% 174
2014
Q1 		$8.59M Sell
123,000
-300,378
-71% -$23.8M 0.51% 69
2013
Q4 		$35.8M Buy
+423,378
New +$33.5M 1.31% 20

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Zweig-DiMenna Associates's CELG Position: Q4 2019 in Review

Zweig-DiMenna Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 270,040 shares — an estimated $26.8M sold.

Zweig-DiMenna Associates first reported a position in CELG in Q4 2013 and held it in 10 quarters. The position peaked at $42.6M in Q3 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Zweig-DiMenna Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 270,040 Celgene Corp shares in Q4 2019, an estimated $26.8M.
  • Zweig-DiMenna Associates first reported a position in Celgene Corp in Q4 2013 and held it in 10 quarters.
  • Zweig-DiMenna Associates's Celgene Corp position peaked at $42.6M in Q3 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2019, filed 30 Jan 2020.